Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
BNF presentation directory
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
Active filters
- Chemical substance: Tetracosactide
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Tetracosactide 250micrograms/1ml inj ampoules
0605010T0AAAAAA
|
Tetracosactide | Tetracosactide | Endocrine System | 17 |
|
Synacthen 250micrograms/1ml solution for injection ampoules
0605010T0BBAAAA
|
Synacthen | Tetracosactide | Endocrine System | 16 |
|
Synacthen Depot 1mg/1ml suspension for injection ampoules
0605010T0BBABAB
|
Synacthen | Tetracosactide | Endocrine System | No data available |
|
Tetracosactide 1mg/1ml suspension for injection ampoules
0605010T0AAABAB
|
Tetracosactide | Tetracosactide | Endocrine System | No data available |
Why monitor BNF codes?
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Understand demand drivers
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.